Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$68.55 n/a | n/a%
04/28/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 30.39B 32.64B 24.89B 11.20B
Cost of Sales 3.10B 2.91B 2.74B 2.51B
Gross Operating Profit 27.29B 29.73B 22.15B 8.69B
Selling, General, and Administrative Expenses 3.40B 3.43B 2.98B 1.70B
Research & Development 5.10B 3.01B 2.85B 2.12B
Operating Income before D & A (EBITDA) 18.79B 23.29B 16.32B 4.87B
Depreciation & Amortization 1.16B 1.10B 1.05B 345.00M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 428.00M 154.00M 3.00M -9.00M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 18.06B 22.35B 15.27B 4.51B
Interest Expense 964.00M 688.00M 412.00M 307.00M
Pre-Tax Income 17.10B 21.66B 14.86B 4.21B
Income Taxes 3.61B 3.55B 2.80B 1.15B
Minority Interest -13.00M -2.00M -42.00M -18.00M
Net Income From Continuing Operations 13.49B 18.11B 12.06B 3.06B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 13.49B 18.11B 12.06B 3.06B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 13.50B 18.11B 12.10B 3.08B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
13.49B 18.11B 12.06B 3.06B
Preferred Dividends
Net Income Available To Common 13.49B 18.11B 12.06B 3.06B
Basic EPS from Continuing Ops. 10.08 12.37 7.95 2.01
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 10.08 12.37 7.95 2.01
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 10.08 12.37 7.95 2.01
Basic Normalized Net Income/Share 10.08 12.37 7.95 2.01
EPS fr Continuing Ops. 9.94 11.91 7.35 1.81
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 9.94 11.91 7.35 1.81
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 9.94 11.91 7.35 1.81
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
9.94 11.91 7.35 1.81
Dividends Paid per Share 1.84 1.29 0.00 0.00

Portfolios with GILD

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter